I. Benko et al., Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia, N-S ARCH PH, 363(5), 2001, pp. 499-508
The aim of this study was to see whether pleiotropic or myeloid hematopoiet
ic growth factors, which do not stimulate normal lymphoid cells, can induce
proliferation of blast cells of the acute lymphoid leukemia (ALL) of child
hood. Bone marrow cells of 13 children with untreated ALL (nine common ALL,
two myeloid antigen positive ALL and two early T-cell ALL) formed colonies
of leukemic blast cells in primary methylcellulose cultures. Spontaneous g
rowth was observed in three of 13 cases, whereas phytohemagglutinin-stimula
ted leukocyte conditioned medium (PHA-LCM), a conventional source of variou
s natural human cytokines, induced colony formation in ten of 13 cases. A s
imilar rate of responsiveness was seen with recombinant human granulocyte c
olony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating
factor (GM-CSF) and stem cell factor (SCF); a combination of these three c
ytokines induced colony formation in all cases studied. The effect of these
growth factors on colony formation seemed to be dose-dependent in some cas
es. Of the stimuli studied, GM-CSF induced the smallest number of colonies,
whereas the effects of G-CSF, SCF and PHA-LCM were similar in this respect
. Combination of cytokines proved to be even more efficient in inducing clo
nal proliferation of leukemic lymphoblasts. In double combinations, G-CSF a
nd GM-CSF as well as G-CSF and SCF were able to potentiate each other's eff
ects. Triple combination of these cytokines mediated the most potent growth
stimulus.
Our results demonstrate that myeloid and pleiotropic cytokines are able to
stimulate clonal proliferation of pediatric leukemic lymphoblasts. This may
present a potential hazard to children with ALL while on adjuvant therapy
with hematopoietic growth factors. In vitro colony assays performed prior t
o or in parallel with the administration of hematopoietic growth factors to
ALL patients map help to forecast their possible effects on leukemic cells
in vivo.